Effects of pomegranate peel dry extract supplementation on non-alcoholic fatty liver

Phase 3

Recruiting

• Conditions: non alcoholic fatty liver- hepatic steatosis and fibrosis- pomegranate peel.; Fatty (Chang of) liver, not elsewhere classified, Nonalcoholic fatty liver disease; K76.0

• Registration Number: IRCT20210726051988N1
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 1 November 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 54

Inclusion Criteria

18-60 years old
Detection of hepatic steatosis by two-dimensional elastography device
Filling out the informed consent form by the patient

Exclusion Criteria

Pregnancy and lactation
Morbid obesity (BMI > 40)
Alcohol consumption history (more than 20 grams per day for women and more than 30 grams per day for men),
Having any type of immunodeficiency disorder, including: autoimmune disorders, cancer, human immunodeficiency virus (HIV)
Hepatic or renal insufficiency, other liver diseases such as hepatitis, alcoholic fatty liver
consumption of hepatotoxic drugs such as sodium valproate
History of food allergy to pomegranate and herbal supplements
History of bariatric surgery

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hepatic steatosis and fibrosis. Timepoint: before and at the end of the study. Method of measurement: Two-dimensional elastography device.